Hostname: page-component-745bb68f8f-cphqk Total loading time: 0 Render date: 2025-01-24T23:04:54.706Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis of Central Nervous System Lupus

Published online by Cambridge University Press:  18 September 2015

Paul O'Connor
Paul O'Connor*
Affiliation:
Women's College Hospital, University of Toronto, Toronto
*
Women's College Hospital, Burton Hall, Suite 514, 60 Grosvenor Street, Toronto, Ontario, Canada M5S 1B6
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Central nervous system (CNS) involvement in systemic lupus erythematosus is a major source of patient morbidity and mortality. The recognition of nervous system lupus is hampered by the diagnostic insensitivity and non-specificity of the various testing modalities that are currently available. A review of the effectiveness of diagnostic tests for CNS lupus is presented. Areas of current research in this area are examined. Because of the diversity of neurologic manifestations in this disorder and their complex pathogenesis, no single test is sufficient to establish the diagnosis rapidly and accurately in all cases, now or for the foreseeable future.

Type
Special Features And Reviews
Information
Canadian Journal of Neurological Sciences , Volume 15 , Issue 3 , August 1988 , pp. 257 - 260
Copyright
Copyright © Canadian Neurological Sciences Federation 1988

References

REFERENCES

1.Dubois, EL, Tuffanelli, DL.Clinical manifestations of SLE: computer analysis of 520 cases. JAMA 1964; 190: 104–111.CrossRefGoogle Scholar
2.Johnson, RT, Richardson, EP.The neurologic manifestations of SLE. Medicine (Baltimore) 1968; 47: 337–369.CrossRefGoogle Scholar
3.Zvaifler, NJ, Bluestein, HG.The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 862–866.CrossRefGoogle ScholarPubMed
4.Small, P, Mass, MF, Kohler, PF, et al. Central nervous system involvement in SLE. Arthritis Rheum 1977; 20: 869–878.CrossRefGoogle ScholarPubMed
5.Bluestein, H.Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 1987; 317: 309–311.CrossRefGoogle ScholarPubMed
6.Kaell, AT, Shetty, M, Lee, BP, et al. The diversity of neurologic events in SLE. Arch Neurol 1986; 43: 273–276.CrossRefGoogle Scholar
7.Carbotte, RM, Denburg, SD, Denburg, JA.Prevalence of cognitive impairment in SLE. J Nerv Ment Dis 1986; 174: 357–363.CrossRefGoogle Scholar
8.How, A, Dent, PB, Liao, SK, et al. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1985; 28: 789–95.CrossRefGoogle ScholarPubMed
9.Wilson, HA, Winfield, JB, Rahita, RG, et al. Association of IgG antibrain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 458–462.CrossRefGoogle ScholarPubMed
10.Bresnihan, B, Oliver, M, Williams, B, et al. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 313–320.CrossRefGoogle ScholarPubMed
11.Bluestein, HG.Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci 1978; 75: 3965–9.CrossRefGoogle ScholarPubMed
12.Bluestein, HG, Woods, VL Jr., Antineuronal antibodies in SLE. Arthritis Rheum 1982; 25: 773–778.CrossRefGoogle Scholar
13.Hirohata, S, Hirose, S, Miyamoto, T.CSF, IgG, IgA, and IgM indexes in SLE. Arch Intern Med 1985; 143: 1843–1846.CrossRefGoogle Scholar
14.Ernerudh, J, Olsson, T, Lindstrom, F, et al. CSF immunoglobulin abnormalities in SLE. J Neurol Neurosurg Psychiatry 1985; 48: 807–813.CrossRefGoogle Scholar
15.Bonfa, E, Golombek, S, Kaufman, L, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265–71.CrossRefGoogle ScholarPubMed
16.Bonfa, E, Elkon, KB.Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum 1986; 19: 981–5.CrossRefGoogle Scholar
17.Feinglass, EJ, Arnett, FC, Dorch, CA, et al. Neuropsychiatric manifestations of SLE: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine (Baltimore) 1976; 55: 323–339.CrossRefGoogle ScholarPubMed
18.Tan, RF, Gladman, DD, Urowitz, MB, et al. Brain scan diagnosis of central nervous system involvement in SLE. Ann Rheum Dis 1978; 37: 357–362.CrossRefGoogle Scholar
19.Gibson, T, Myers, AR.Nervous system involvement in SLE. Ann Rheum Dis 1976; 35: 398–406.CrossRefGoogle Scholar
20.Feinglass, EJ, Arnett, FC, Dorch, CA, et al. Neuropsychiatric manifestationsof SLE: diagnosis, clinical spectrum and relationship to other features of the disease. Medicine (Baltimore) 1976; 55: 323–339.CrossRefGoogle Scholar
21.Gonzalez-Scarano, F, Lisak, RP, Bilaniuk, LT, et al. Cranial CT in the diagnosis of SLE. Ann Neurol 1979; 5: 158–165.Google Scholar
22.Gaylis, NB, Altman, RD, Ostrov, S, et al. The selective value of CT of the brain in cerebritis due to SLE. J Rheumatol 1982; 9: 850–854.Google Scholar
23.Carette, S, Urowitz, MB, Grossman, H, et al. Cranial computerized tomography in SLE. J Rheumatol 1982; 9: 855–859.Google Scholar
24.Ostrov, SG, Quencer, RM, Gaylis, NB, et al. Cerebral atrophy in SLE: steroid or disease induced phenomenon?. AJNR 1982; 3: 21–23.Google ScholarPubMed
25.Killian, PJ, Schnapf, DJ, Lawless, OJ.CAT of CNS lupus (abstr). Arthritis Rheum 1979; 22: 628–629.Google Scholar
26.Betson, J, Reag, M, Winter, J, et al. Steroids and apparent cerebral atrophy on computed tomography. J Comput Assist Tomogr 1978; 2: 16–23.CrossRefGoogle Scholar
27.Vermess, M, Bernstein, RM, Bydder, GM, et al. Nuclear magnetic resonance imaging of the brain in SLE. J Comput Assist Tomogr 1983; 7: 461–467.CrossRefGoogle Scholar
28.Aisen, AA, Gabrielsen, TO, McCune, WJ, et al. MR imaging of systemic lupus erythematosus involving the brain. AJR 1985; 144: 1027–1031.CrossRefGoogle ScholarPubMed
29.Levine, SR, Welch, KMA. Cerebrovascular ischemia associated with lupus anticoagulant. Stroke 1987; 18: 257–63.CrossRefGoogle ScholarPubMed